Petros Nikolaos Karamanakos

Summary

Affiliation: Kuopio University Hospital
Country: Finland

Publications

  1. ncbi Malignant giant cell tumor in the posterior fossa of a neonate
    Petros N Karamanakos
    Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland
    J Neurosurg Pediatr 5:277-82. 2010
  2. ncbi Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines
    Petros N Karamanakos
    Department of Pharmacology, Medical School, University of Ioannina, Ioannina, Greece
    Int J Toxicol 26:423-32. 2007
  3. ncbi Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity
    Petros Nikolaos Karamanakos
    Department of Pharmacology, Medical School, University of Ioannina, 45110 Ioannina, Greece
    Arch Toxicol 83:571-80. 2009
  4. ncbi The impact of endovascular management on the outcome of aneurysmal subarachnoid hemorrhage in the elderly in eastern Finland
    Petros Nikolaos Karamanakos
    Department of Neurosurgery, Kuopio University Hospital, Puijonlaaksontie 2, 70211 Kuopio, Finland
    Acta Neurochir (Wien) 152:1493-502. 2010
  5. ncbi Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors
    Petros N Karamanakos
    Department of Pharmacology, Medical School, University of Ioannina, University Campus, 45110 Ioannina, Greece
    Behav Brain Res 148:199-208. 2004

Detail Information

Publications5

  1. ncbi Malignant giant cell tumor in the posterior fossa of a neonate
    Petros N Karamanakos
    Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland
    J Neurosurg Pediatr 5:277-82. 2010
    ..In addition, the extremely high growth rate of the tumor in the postoperative period renders this case the most aggressive primary malignant GCT of the cranium described so far...
  2. ncbi Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines
    Petros N Karamanakos
    Department of Pharmacology, Medical School, University of Ioannina, Ioannina, Greece
    Int J Toxicol 26:423-32. 2007
    ....
  3. ncbi Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity
    Petros Nikolaos Karamanakos
    Department of Pharmacology, Medical School, University of Ioannina, 45110 Ioannina, Greece
    Arch Toxicol 83:571-80. 2009
    ..Our results, even preliminary, indicate that quinacrine as an inhibitor of CYP2E1 might be protective against chemically-induced toxicities such as NNK-induced mutagenicity...
  4. ncbi The impact of endovascular management on the outcome of aneurysmal subarachnoid hemorrhage in the elderly in eastern Finland
    Petros Nikolaos Karamanakos
    Department of Neurosurgery, Kuopio University Hospital, Puijonlaaksontie 2, 70211 Kuopio, Finland
    Acta Neurochir (Wien) 152:1493-502. 2010
    ..We feel that this generalization requires further investigation to assess its validity...
  5. ncbi Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors
    Petros N Karamanakos
    Department of Pharmacology, Medical School, University of Ioannina, University Campus, 45110 Ioannina, Greece
    Behav Brain Res 148:199-208. 2004
    ..Moreover, this behavioral component of CPA seems to be primarily mediated via the postsynaptic 5-HT1A receptors...